BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34571267)

  • 1. A novel non-invasive score for the prediction of advanced fibrosis in patients with chronic hepatitis B.
    Okdemir S; Cakmak E
    Ann Hepatol; 2022; 27(1):100544. PubMed ID: 34571267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of different noninvasive scores for detecting advanced fibrosis in chronic hepatitis B.
    Hamidi AA; Oncul A; Ozguven BY; Sevgi DY; Gunduz A; Uzun N; Dokmetas I
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1439-1443. PubMed ID: 31033847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of a novel noninvasive index for predicting significant fibrosis, advanced fibrosis, and cirrhosis in patients with chronic hepatitis B infection.
    Kayadibi H; Yilmaz B; Ozgur Yeniova A; Koseoglu H; Simsek Z
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e121-e130. PubMed ID: 33177385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients.
    Erdogan S; Dogan HO; Sezer S; Uysal S; Ozhamam E; Kayacetin S; Koca Y
    Scand J Clin Lab Invest; 2013; 73(4):300-8. PubMed ID: 23514016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive models for the prediction of liver fibrosis in patients with chronic hepatitis B.
    Wang J; Sun X; Wei S; Chen X; Zhu H; Liantang Y; Bao R; Du Y
    BMC Gastroenterol; 2024 May; 24(1):183. PubMed ID: 38783185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.
    Wang J; Chen Z; Yan X; Yang Y; Liu Y; Chen Y; Jia B; Xia J; Xiong Y; Zhang Z; Ding W; Huang R; Wu C
    Discov Med; 2019 Sep; 28(153):149-158. PubMed ID: 31926586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
    Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPR, King's Score and S-Index are superior to other non-invasive fibrosis markers in predicting the liver fibrosis in chronic Hepatitis B patients.
    Ekin N; Ucmak F; Ebik B; Tugba Tuncel E; Kacmaz H; Arpa M; Engin Atay A
    Acta Gastroenterol Belg; 2022; 85(1):62-68. PubMed ID: 35304995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
    Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
    [No Abstract]   [Full Text] [Related]  

  • 10. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
    Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
    Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of simple noninvasive scoring systems for the prediction of advanced fibrosis in patients with chronic hepatitis B.
    Lang S; Kütting F; Staub A; Schramowski J; Schramm C; Kasper P; Goeser T; Steffen HM; Demir M
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1235-1240. PubMed ID: 28885276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.
    Wang RQ; Zhang QS; Zhao SX; Niu XM; Du JH; Du HJ; Nan YM
    J Int Med Res; 2016 Dec; 44(6):1302-1313. PubMed ID: 28322102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of noninvasive indices in chronic hepatitis B virus-related fibrosis.
    Öznur M; Topçu B; Çelikkol A
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):577-582. PubMed ID: 33657603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
    Eminler AT; Ayyildiz T; Irak K; Kiyici M; Gurel S; Dolar E; Gulten M; Nak SG
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1361-6. PubMed ID: 26352130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?
    Desalegn H; Aberra H; Berhe N; Gundersen SG; Johannessen A
    Liver Int; 2017 Oct; 37(10):1461-1467. PubMed ID: 28222249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
    Yue W; Li Y; Geng J; Wang P; Zhang L
    Medicine (Baltimore); 2019 Dec; 98(49):e18038. PubMed ID: 31804310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
    Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
    Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.